Source: Journal of Pharmacy and Pharmacology. Unidade: FCF
Subjects: NANOPARTÍCULAS, LIPOPROTEÍNAS, NEOPLASIAS
ABNT
CONTENTE, Thais Costa et al. Association of daunorubicin to a lipid nanoemulsion that binds to low-density lipoprotein receptors enhances the antitumour action and decreases the toxicity of the drug in melanoma-bearing mice. Journal of Pharmacy and Pharmacology, v. 66, n. 12, p. 1698-1709, 2014Tradução . . Disponível em: https://doi.org/10.1111/jphp.12296. Acesso em: 28 set. 2024.APA
Contente, T. C., Kretzer, I. F., Monteiro, F. B. F., Maria, D. A., & Maranhão, R. C. (2014). Association of daunorubicin to a lipid nanoemulsion that binds to low-density lipoprotein receptors enhances the antitumour action and decreases the toxicity of the drug in melanoma-bearing mice. Journal of Pharmacy and Pharmacology, 66( 12), 1698-1709. doi:10.1111/jphp.12296NLM
Contente TC, Kretzer IF, Monteiro FBF, Maria DA, Maranhão RC. Association of daunorubicin to a lipid nanoemulsion that binds to low-density lipoprotein receptors enhances the antitumour action and decreases the toxicity of the drug in melanoma-bearing mice [Internet]. Journal of Pharmacy and Pharmacology. 2014 ; 66( 12): 1698-1709.[citado 2024 set. 28 ] Available from: https://doi.org/10.1111/jphp.12296Vancouver
Contente TC, Kretzer IF, Monteiro FBF, Maria DA, Maranhão RC. Association of daunorubicin to a lipid nanoemulsion that binds to low-density lipoprotein receptors enhances the antitumour action and decreases the toxicity of the drug in melanoma-bearing mice [Internet]. Journal of Pharmacy and Pharmacology. 2014 ; 66( 12): 1698-1709.[citado 2024 set. 28 ] Available from: https://doi.org/10.1111/jphp.12296